HGINFRA.BO(HGINFRA.BO)
HGINFRA.BO
No analyst ratings available
No analyst price targets available for HGINFRA.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $62.08B | $70.23B | $83.80B |
| Low | $55.75B | $64.22B | $83.80B |
| High | $68.59B | $86.71B | $83.80B |
| EBITDA Avg | $12.33B | $13.95B | $16.65B |
| Low | $11.07B | $12.76B | $16.65B |
| High | $13.63B | $17.22B | $16.65B |
| EBIT Avg | $10.81B | $12.23B | $14.59B |
| Low | $9.71B | $11.18B | $14.59B |
| High | $11.95B | $15.10B | $14.59B |
| Net Income Avg | $5.67B | $4.97B | $6.43B |
| Low | $2.72B | $3.79B | $6.09B |
| High | $5.77B | $7.17B | $8.50B |
| EPS Avg | $66.50 | $82.17 | $106.17 |
| Low | $41.60 | $58.00 | $93.30 |
| High | $88.33 | $109.86 | $130.24 |
| Analysts (Rev / EPS) | 10 / 8 | 11 / 10 | 3 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|---|
| Revenue Avg | $13.43B | $11.43B | $15.14B | $17.14B |
| Low | $13.43B | $11.43B | $15.14B | $17.14B |
| High | $13.43B | $11.43B | $15.14B | $17.14B |
| EBITDA Avg | $2.67B | $2.27B | $3.01B | $3.40B |
| Low | $2.67B | $2.27B | $3.01B | $3.40B |
| High | $2.67B | $2.27B | $3.01B | $3.40B |
| EBIT Avg | $2.34B | $1.99B | $2.64B | $2.98B |
| Low | $2.34B | $1.99B | $2.64B | $2.98B |
| High | $2.34B | $1.99B | $2.64B | $2.98B |
| Net Income Avg | $524M | $249M | $721M | $956M |
| Low | $524M | $249M | $721M | $956M |
| High | $524M | $249M | $721M | $956M |
| EPS Avg | $8.00 | $3.80 | $11.00 | $14.60 |
| Low | $8.00 | $3.80 | $11.00 | $14.60 |
| High | $8.00 | $3.80 | $11.00 | $14.60 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |